» Articles » PMID: 23317785

Melanocortin-4 Receptor in Energy Homeostasis and Obesity Pathogenesis

Overview
Specialty Molecular Biology
Date 2013 Jan 16
PMID 23317785
Citations 63
Authors
Affiliations
Soon will be listed here.
Abstract

The melanocortin-4 receptor gene (MC4R) has intensively been analyzed in molecular genetic obesity research. Decreased MC4R activity leads to obesity. Currently 166 nonsynonymous, nonsense, deletion, and frameshift MC4R mutations have been described. Vast numbers of these mutations were identified in (extremely) obese individuals. Total or partial loss of MC4R function results from most detected mutations, as shown by in vitro analyses. The heterozygote frequency for these mutations in (extremely) obese individuals cumulates to approximately 2-5%. Surprisingly, two polymorphisms in the MC4R are associated with a slight protection from obesity. Large study groups were screened to be able to pinpoint these rather small effects on body weight. Recently, the advent of genome-wide association studies led to the discovery of association of polymorphisms in the 3' region of the MC4R with obesity. The functional implication of the finding is still unresolved; an effect on gene expression is the most likely mechanism. Synthetic association could not be detected for the MC4R region.

Citing Articles

MC4R Variants Modulate α-MSH and Setmelanotide Induced Cellular Signaling at Multiple Levels.

Rodriguez Rondon A, Welling M, van den Akker E, van Rossum E, Boon E, van Haelst M J Clin Endocrinol Metab. 2024; 109(10):2452-2466.

PMID: 38567654 PMC: 11403317. DOI: 10.1210/clinem/dgae210.


Divergent Pharmacology and Biased Signaling of the Four Melanocortin-4 Receptor Isoforms in Rainbow Trout ().

Ji R, Liu T, Hou Z, Wen H, Tao Y Biomolecules. 2023; 13(8).

PMID: 37627313 PMC: 10452266. DOI: 10.3390/biom13081248.


Rare genetic forms of obesity in childhood and adolescence, a comprehensive review of their molecular mechanisms and diagnostic approach.

Mainieri F, La Bella S, Rinaldi M, Chiarelli F Eur J Pediatr. 2023; 182(11):4781-4793.

PMID: 37607976 DOI: 10.1007/s00431-023-05159-x.


Neuroendocrine Effects on the Risk of Metabolic Syndrome in Children.

Scorrano G, La Bella S, Matricardi S, Chiarelli F, Giannini C Metabolites. 2023; 13(7).

PMID: 37512517 PMC: 10383317. DOI: 10.3390/metabo13070810.


Natural products targeting inflammation-related metabolic disorders: A comprehensive review.

Nainu F, Frediansyah A, Mamada S, Permana A, Salampe M, Chandran D Heliyon. 2023; 9(6):e16919.

PMID: 37346355 PMC: 10279840. DOI: 10.1016/j.heliyon.2023.e16919.